[ad_1]
Hutin Y, Nasrullah M, Easterbrook P, Nguimfack BD, Burrone E, Averhoff F, Bulterys M. Access to Treatment for Hepatitis B Virus infection – Worldwide, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(28):773–7 .
Google Scholar
Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of HBsAg seroprevalence and endemicity by age. Vaccine. 2012;30(12):2212–9.
Google Scholar
Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. American Association for the Study of Liver D: AASLD guidelines for the treatment of chronic hepatitis B. Hepatology. 2016;63(1):261–83.
Google Scholar
Kim SW, Yoon JS, Lee M, Cho Y. Towards a complete cure for chronic hepatitis B: new therapeutic targets for the hepatitis B virus. Clin Mol Hépatol. 2022;28(1):17–30.
Google Scholar
Inoue T, Tanaka Y. New biomarkers for the management of chronic hepatitis B. Clin Mol Hepatol. 2020;26(3):261–79.
Google Scholar
Yim HJ, Kim JH, Park JY, Yoon EL, Park H, Kwon JH, Sinn DH, Lee SH, Lee JH, Lee HW. Comparison of clinical practice guidelines for the management of chronic hepatitis B: when to start, when to switch and when to stop. Clin Mol Hepatol. 2020;26(4):411–29.
Google Scholar
Ganem D, Prince AM. Hepatitis B virus infection – natural history and clinical consequences. N Engl J Med. 2004;350(11):1118–29.
Google Scholar
Korean Association for the Study of L. KASL Clinical Practice Guidelines for the Management of Chronic Hepatitis B. Clin Mol Hepatol. 2022;28(2):276–331.
Google Scholar
Schiff ER, Lee SS, Chao YC, Kew Yoon S, Bessone F, Wu SS, Kryczka W, Lurie Y, Gadano A, Kitis G, et al. Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B. Clin Gastroenterol Hepatol. 2011;9(3):274–6.
Google Scholar
Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, Washington MK, Germanidis G, Flaherty JF, Aguilar Schall R, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013;381(9865):468–75.
Google Scholar
Chang TT, Liaw YF, Wu SS, Schiff E, Han KH, Lai CL, Safadi R, Lee SS, Halota W, Goodman Z, et al. Long-term treatment with entecavir results in reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology. 2010;52(3):886–93.
Google Scholar
Marcellin P, Chang TT, Lim SG, Sievert W, Tong M, Arterburn S, Borroto-Esoda K, Frederick D, Rousseau F. Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e hepatitis chronic positive for antigen B. Hepatology. 2008;48(3):750–8.
Google Scholar
Dienstag JL, Goldin RD, Heathcote EJ, Hann HW, Woessner M, Stephenson SL, Gardner S, Gray DF, Schiff ER. Histological outcome during long-term treatment with lamivudine. Gastroenterology. 2003;124(1):105–17.
Google Scholar
Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344(7):495–500.
Google Scholar
Bedossa P, Carrat F. Liver biopsy: the best, not the gold standard. J Hepatol. 2009;50(1):1–3.
Google Scholar
Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Feng ZZ, Reddy KR, Schiff ER. Sampling error and intra-observer variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97(10):2614–8.
Google Scholar
Kuo YH, Lu SN, Chen CH, Chang KC, Hung CH, Tai WC, Tsai MC, Tseng PL, Hu TH, Wang JH. Changes in hepatic stiffness and its associated factors in patients with chronic hepatitis B treated with entecavir. PLOS ONE. 2014;9(3):e93160.
Google Scholar
Chon YE, Park JY, Myoung SM, Jung KS, Kim BK, Kim SU, Kim DY, Ahn SH, Han KH. Improvement in liver fibrosis after long-term antiviral therapy assessed by Fibroscan in chronic hepatitis B patients with advanced fibrosis. Am J Gastroenterol. 2017;112(6):882–91.
Google Scholar
Kim MN, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Han KH. Long-term changes in hepatic stiffness values assessed by transient elastography in patients with chronic hepatitis B receiving entecavir. Liver Int. 2014;34(8):1216–23.
Google Scholar
Chon YE, Jung KS, Ha Y, Kim MN, Lee JH, Hwang SG, Ahn SH, Kim DY, Han KH, Park JY. High body mass index impairs fibrosis improvement in patients receiving long-term tenofovir therapy for hepatitis B virus-related cirrhosis. J Viral Hepat. 2020;27(11):1119–26.
Google Scholar
Stasi C, Salomoni E, Arena U, Corti G, Montalto P, Bartalesi F, Marra F, Laffi G, Milani S, Zignego AL, et al. Noninvasive assessment of liver fibrosis in patients with HBV-related chronic liver disease on antiviral therapy: a preliminary study. Eur J Pharmacol. 2017;806:105–9.
Google Scholar
Wang HM, Hung CH, Lee CM, Lu SN, Wang JH, Yen YH, Kee KM, Chang KC, Tseng PL, Hu TH, et al. Efficacy and Safety of Tenofovir Over Three Years in Nucleos
PubMed
Google Scholar
Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: practical advice from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328–57.
Google Scholar
Kang SH, Lee HW, Yoo JJ, Cho Y, Kim SU, Lee TH, Jang BK, Kim SG, Ahn SB, Kim H, et al. KASL clinical practice guidelines: management of non-alcoholic fatty liver disease. Clin Mol Hepatol. 2021;27(3):363–401.
Google Scholar
Chang PE, Goh GB, Ngu JH, Tan HK, Tan CK. Clinical applications, limitations and future role of transient elastography in the management of liver disease. World J Gastrointest Pharmacol Ther. 2016;7(1):91–106.
Google Scholar
Boursier J, Zarski JP, de Ledinghen V, Rousselet MC, Sturm N, Lebail B, Fouchard-Hubert I, Gallois Y, Oberti F, Bertrais S, et al. Determination of reliability criteria for the evaluation of hepatic stiffness by transient elastography. Hepatology. 2013;57(3):1182–91.
Google Scholar
Kim SS, Hwang JC, Lim SG, Ahn SJ, Cheong JY, Cho SW. Effect of virologic response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis. Am J Gastroenterol. 2014;109(8):1223–33.
Google Scholar
Jung SK, Kim KA, Ha SY, Lee HK, Kim YD, Lee BH, Paik WH, Kim JW, Bae WK, Kim NH, et al. Tenofovir disoproxil fumarate monotherapy for nucleos
PubMed
PubMed Center
Google Scholar
European Association for the Study of the Liver. Email address eee, European Association for the Study of L: EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370–98.
Google Scholar
Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Ledinghen V, Marcellin P, Dhumeaux D, Trinchet JC, et al. Noninvasive evaluation of hepatic fibrosis by measuring stiffness in patients with chronic hepatitis C. Hepatology. 2005;41(1):48–54.
Google Scholar
Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de Ledinghen V, Beaugrand M. Noninvasive evaluation of liver fibrosis by measuring stiffness in patients with chronic hepatitis B. Foie Int. 2009;29(2):242–7.
Google Scholar
de Ledinghen V, Douvin C, Kettaneh A, Ziol M, Roulot D, Marcellin P, Dhumeaux D, Beaugrand M. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in patients co-infected with the HIV/hepatitis C virus J Acquire Immune Defic Syndr. 2006;41(2):175–9.
Google Scholar
Corpechot C, El Naggar A, Poujol-Robert A, Ziol M, Wendum D, Chazouilleres O, de Ledinghen V, Dhumeaux D, Marcellin P, Beaugrand M, et al. Evaluation of biliary fibrosis by transient elastography in patients with PBC and CSP. Hepatology. 2006;43(5):1118–24.
Google Scholar
Ogawa E, Furusyo N, Murata M, Ohnishi H, Toyoda K, Taniai H, Ihara T, Ikezaki H, Hayashi T, Kainuma M, et al. Longitudinal evaluation of hepatic stiffness by transient elastography in patients with chronic hepatitis B treated with nucleoside analogue. Hepatol Res. 2011;41(12):1178–88.
Google Scholar
Park ES, Lee AR, Kim DH, Lee JH, Yoo JJ, Ahn SH, Sim H, Park S, Kang HS, Won J, et al. Identification of a quadruple mutation that confers resistance to tenofovir in patients with chronic hepatitis B. J Hepatol. 2019;70(6):1093–102.
Google Scholar
Fung J, Lai CL, But D, Hsu A, Seto WK, Cheng C, Wong DK, Yuen MF. Reduction of liver stiffness following resolution of acute attacks of chronic hepatitis B. Hepatol Int. 2010;4(4):716–22.
Google Scholar
Vigano M, Massironi S, Lampertico P, Iavarone M, Paggi S, Pozzi R, Conte D, Colombo M. Transient elastography assessment of the dynamics of liver stiffness during acute hepatitis B. Eur J Gastroenterol Hepatol. 2010;22(2):180–4.
Google Scholar
|
Sources 2/ https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-023-02846-9 The mention sources can contact us to remove/changing this article |
[ad_2]